APA (7th ed.) Citation

WS, T., JE, B., & PS, G. (2020). Breast core needle biopsy may be sole determinant of pathologic tumor (pT) category and the only specimen available for ancillary testing. The breast journal, 26(4), 797. https://doi.org/10.1111/tbj.13612

Chicago Style (17th ed.) Citation

WS, Towne, Baum JE, and Ginter PS. "Breast Core Needle Biopsy May Be Sole Determinant of Pathologic Tumor (pT) Category and the Only Specimen Available for Ancillary Testing." The Breast Journal 26, no. 4 (2020): 797. https://doi.org/10.1111/tbj.13612.

MLA (9th ed.) Citation

WS, Towne, et al. "Breast Core Needle Biopsy May Be Sole Determinant of Pathologic Tumor (pT) Category and the Only Specimen Available for Ancillary Testing." The Breast Journal, vol. 26, no. 4, 2020, p. 797, https://doi.org/10.1111/tbj.13612.